Aberdeen Group
EXAS

Aberdeen Group’s Exact Sciences EXAS Stock Holding History

Aberdeen Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-304,609
Closed -$16.7M – 955
2025
Q3 		$16.7M Buy
304,609
+105,138
+53% +$5.25M 0.03% 489
2025
Q2 		$10.6M Buy
199,471
+26,906
+16% +$1.37M 0.02% 581
2025
Q1 		$7.47M Buy
172,565
+110,924
+180% +$5.62M 0.01% 627
2024
Q4 		$3.46M Buy
61,641
+55,104
+843% +$3.43M 0.01% 701
2024
Q3 		$445K Sell
6,537
-81,941
-93% -$4.62M ﹤0.01% 857
2024
Q2 		$3.74M Sell
88,478
-21,855
-20% -$1.2M 0.01% 680
2024
Q1 		$7.62M Buy
110,333
+4,227
+4% +$267K 0.01% 595
2023
Q4 		$7.85M Buy
106,106
+34,494
+48% +$2.26M 0.02% 595
2023
Q3 		$4.89M Buy
71,612
+2,992
+4% +$254K 0.01% 561
2023
Q2 		$6.44M Buy
68,620
+4,643
+7% +$362K 0.02% 538
2023
Q1 		$4.34M Buy
63,977
+15,411
+32% +$991K 0.01% 600
2022
Q4 		$2.4M Buy
48,566
+6,025
+14% +$246K 0.01% 682
2022
Q3 		$1.38M Buy
42,541
+19,951
+88% +$823K ﹤0.01% 749
2022
Q2 		$890K Buy
22,590
+2,005
+10% +$107K ﹤0.01% 800
2022
Q1 		$1.48M Buy
20,585
+2,651
+15% +$194K ﹤0.01% 778
2021
Q4 		$1.4M Buy
17,934
+356
+2% +$31.4K ﹤0.01% 829
2021
Q3 		$1.68M Buy
17,578
+4,189
+31% +$442K ﹤0.01% 815
2021
Q2 		$1.66M Sell
13,389
-2,465
-16% -$294K ﹤0.01% 804
2021
Q1 		$2.09M Buy
15,854
+178
+1% +$24.4K ﹤0.01% 758
2020
Q4 		$2.08M Buy
15,676
+543
+4% +$65.7K 0.01% 737
2020
Q3 		$1.54M Sell
15,133
-4,132
-21% -$357K ﹤0.01% 743
2020
Q2 		$1.68M Buy
19,265
+804
+4% +$64.2K ﹤0.01% 724
2020
Q1 		$1.07M Buy
18,461
+353
+2% +$28.7K ﹤0.01% 757
2019
Q4 		$1.67M Buy
18,108
+1,086
+6% +$95.5K ﹤0.01% 744
2019
Q3 		$1.54M Buy
17,022
+9,800
+136% +$1.12M ﹤0.01% 748
2019
Q2 		$852K Buy
+7,222
New +$728K ﹤0.01% 837

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aberdeen Group's EXAS Position: Q4 2025 in Review

Aberdeen Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 304,609 shares — an estimated $16.7M sold.

Aberdeen Group first reported a position in EXAS in Q2 2019 and held it in 26 quarters. The position peaked at $16.7M in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Aberdeen Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Aberdeen Group sold 304,609 Exact Sciences shares in Q4 2025, an estimated $16.7M.
  • Aberdeen Group first reported a position in Exact Sciences in Q2 2019 and held it in 26 quarters.
  • Aberdeen Group's Exact Sciences position peaked at $16.7M in Q3 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.